Search for: "Tom Lamb"
Results 481 - 500
of 1,046
Sort by Relevance
|
Sort by Date
4 Mar 2013, 2:20 pm
In the end, we expect that those Beyaz and Safyral blood clot claims will be settled by Bayer eventually -- even if those particular DRSP birth control cases are not being mentioned by the drug company to the same extent that the YAZ, Yasmin, Ocella, and Gianvi claims have been to this point in time. ______________________________________________________________________________ DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects (All website content by… [read post]
25 Feb 2013, 2:33 pm
Of course, we will be watching to see whether these reported allergic reactions and deaths will cause Omontys to be withdrawn from the market. ______________________________________________________________________________ DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects (All website content by attorney Tom Lamb) Drug Injury Case Evaluation - Free & Confidential (Review done by attorney Tom Lamb) [read post]
18 Feb 2013, 2:28 pm
In the alternative, you can get my new blog posts delivered by email using the subscription box seen in the sidebar or use the Drug Injury Watch RSS feed. ______________________________________________________________________________ DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects (All website content by attorney Tom Lamb) Drug Injury Case Evaluation - Free & Confidential (Review done by attorney Tom… [read post]
8 Feb 2013, 7:48 pm
But as the authors make clear in this article, there is a remarkable similarity between the two sets of rare and uncommon sets of diseases associated with bisphosphonate medications (namely, osteonecrosis of the jaw and atypical femur fractures) and the exposure of the match workers ("phossy jaw" and fragile femurs) that suggests there might, in fact, be a common cause at work, here. ______________________________________________________________________________ DrugInjuryLaw.com: Legal… [read post]
31 Jan 2013, 1:45 pm
To learn more about the safety problems associated with Pradaxa as well as the types of Pradaxa cases that are getting filed as lawsuits, you can visit the Pradaxa Information page over at our Drug Injury Law web site. ______________________________________________________________________________ DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects (All website content by attorney Tom Lamb) Drug Injury Case Evaluation - Free &… [read post]
23 Jan 2013, 1:38 pm
Lastly, if you are going to be at this Selling Sickness 2013 conference and would like to meet in person, please feel free to send me an email in advance of the event so that I can look for you there. ______________________________________________________________________________ DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects (All website content by attorney Tom Lamb) Drug Injury Case Evaluation - Free & Confidential … [read post]
15 Jan 2013, 2:09 pm
[Footnote omitted] In fact, here, we have heard from women who used Actonel, Boniva, and Fosamax (alone or is some sequential combination) for five years, at least, that have been diagnosed with single leg or bilateral low-stress atypical femur fractures -- albeit this is not the basis for a medical or scientific determination as regards this controversial and still developing drug-safety issue. ______________________________________________________________________________… [read post]
8 Jan 2013, 12:45 pm
This May Be The Final Bellwether Case Trial For IN RE: FOSAMAX PRODUCTS LIABILITY LITIGATION, MDL No. 1789 (Posted by Tom Lamb at DrugInjuryWatch.com) The trial of RHODA E. [read post]
4 Jan 2013, 12:13 pm
Now, more than a year later, one continues to wonder whether the FDA should be doing more -- especially in view of this action now being taken in Europe -- as regards the persistent and serious drug-safety issues surrounding YAZ / Yasmin and NuvaRing. ______________________________________________________________________________ DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects -- All content by attorney Tom Lamb Drug Injury Case Evaluation - Free… [read post]
26 Dec 2012, 1:35 pm
A Look At The Events And The Evidence Leading Up To This Latest FDA Action Concerning The Safety Of Pradaxa (Posted by Tom Lamb at DrugInjuryWatch.com) We set the stage with this December 19, 2012 drug company press release, "Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
21 Dec 2012, 12:44 pm
I anticipate that the discussions will be web-streamed and possibly even on C-SPAN, given the quality of the participants, many of whom have published recent books altogether relevant to the topic, and continuing timeliness of the subject (unless Republican lions and Democratic lambs really are frolicking with one another and we can talk about what has accounted for this unexpected development). [read post]
3 Dec 2012, 2:58 pm
At Least, This November 2012 Article In The New England Journal Of Medicine Makes The Point That Something Needs To Be Done Soon, Rather Than Later (Posted by Tom Lamb at DrugInjuryWatch.com) The June 2011 ruling by our United States Supreme Court in Pliva v. [read post]
26 Nov 2012, 2:35 pm
Bayer Has Settled Less Than Half The DVT And PE Blood Clot Claims Filed Or Cases Subject To Tolling Agreements (Posted by Tom Lamb at DrugInjuryWatch.com) In late October 2012 we received the Bayer Stockholders’ Newsletter which covered its third quarter financial reporting and, in particular, gave us this update about the YAZ, Yasmin, Ocella, and Gianvi products liability litigation ongoing in the U.S.: As of October 15, 2012, the number of lawsuits pending in… [read post]
15 Nov 2012, 2:00 pm
The Relatively New Diabetes Medication Victoza From Novo Nordisk Was Only Approved By FDA In 2010 (Posted by Tom Lamb at DrugInjuryWatch.com) In November 2012 The Annals of Pharmacotherapy published online before print this new medical journal article about Victoza, "Pancreatitis: A Potential Complication of Liraglutide? [read post]
30 Oct 2012, 1:04 pm
Fresenius Failed To Warn About Risks Of Sudden Heart Attack, Stroke, And Death Caused By GranuFlo Increasing The Level Of Bicarbonate In Blood (Posted by Tom Lamb at DrugInjuryWatch.com) The dialysis product GranuFlo from Fresenius was used by approximately one-third of the 400,000 patients with late-stage kidney failure requiring dialysis per year at a time when Fresenius apparently knew that GranuFlo caused an increased risk of metabolic alkalosis that could result in… [read post]
24 Oct 2012, 10:02 am
Defendants Had Sought To Keep Sealed Some Documents That Show NuvaRing Estrogen Levels Were Apparently Concealed Or Misrepresented By Organon (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: A similar Order was issued on October 25, 2012 in the federal court NuvaRing MDL by U.S. [read post]
22 Oct 2012, 12:40 pm
Combination Pill Of Topamax And Phentremine Was Approved By FDA, But EMA Points To Heart Side Effects, Birth Defects, And Other Safety Issues (Posted by Tom Lamb at DrugInjuryWatch.com) On October 18, 2012 European drug regulators took a different course than the FDA with regard to a new anti-obesity medication which contains the active ingredient in Topamax, topiramate, and phentermine. [read post]
15 Oct 2012, 1:58 pm
People Who Suffer These Atypical Femoral Fractures Are Well Treated With This Surgical Procedure Using Rod-Like Nail, With Low Rate Of Complications (Posted by Tom Lamb at DrugInjuryWatch.com) According a recent article about a presentation -- Clinical and functional outcomes in patients who sustained bisphosphonate-associated complete femur fractures. [read post]
9 Oct 2012, 2:37 pm
Concomitant Use Of Tekturna With ACE Inhibitors And ARBs Contraindicated In Patients With Diabetes; Plus An FDA Caution Regarding Renal Impairment (Posted by Tom Lamb at DrugInjuryWatch.com) Tekturna (aliskiren) was approved by the FDA for marketing in March 2007 after it was evaluated for safety in 6,460 patients, and only 1250 patients were treated for longer than 1 year. [read post]
3 Oct 2012, 11:00 am
Newly Available Expert Analysis Of Confidential Drug Company Data Reveals That NuvaRing Estrogen Levels In Studies Were A Cause For Concern, And The Method Of Reporting Was Misleading (Posted by Tom Lamb at DrugInjuryWatch.com) In the pending NuvaRing litigation a federal judge recently unsealed some significant documents previously protected under claims of confidentiality. [read post]
